Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$24.12
-4.12%
Mkt Cap $683.41M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
Implied Upside
+36.8%
Consensus $33.00 vs current $24.12
NASDAQ·Healthcare·Biotechnology
$24.12
-4.12%
Mkt Cap $683.41M
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
+36.8%
Consensus $33.00 vs current $24.12